Anacetrapib

(4S,5R)-5-[3,5-Bis(trifluormethyl)phenyl]-3-{[4′-fluor-5′-isopropyl-2′-methoxy-4-(trifluormethyl)-2-biphenylyl]methyl}-4-methyl-1,3-oxazolidin-2-on

(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4′-fluoro-2′-methoxy-5′-(propan-2-yl)-4-(trifluoromethyl)-[1,1′-biphenyl]-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one

(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-{[4′-fluoro-5′-isopropyl-2′-methoxy-4-(trifluoromethyl)-2-biphenylyl]methyl}-4-methyl-1,3-oxazolidin-2-one

(4S,5R)-5-[3,5-Bis(trifluorométhyl)phényl]-3-{[4′-fluoro-5′-isopropyl-2′-méthoxy-4-(trifluorométhyl)-2-biphénylyl]méthyl}-4-méthyl-1,3-oxazolidin-2-one

2-Oxazolidinone, 5-[3,5-bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-2′-methoxy-5′-(1-methylethyl)-4-(trifluoromethyl)[1,1′-biphenyl]-2-yl]methyl]-4-methyl-, (4S,5R)-

875446-37-0

Anacetrapib

anacétrapib

anacetrapib

anacetrapibum

P7T269PR6S

(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4′-fluoro-5′-isopropyl-2′-methoxy-4-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)methyl)-4-methyloxazolidin-2-one

(4S,5r)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4′-fluoro-5′-isopropyl-2′-methoxy-4-(trifluoromethyl)biphenyl-2-yl)methyl)-4-methyl-1 ,3-oxazolidin-2-one

(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4′-fluoro-5′-isopropyl-2′-methoxy-4-(trifluoromethyl)biphenyl-2-yl)methyl)-4-methyloxazolidin-2-one

(4S,5R)-5-3,5-bis(trifluoromethyl)phenyl-3-(2-4-fluoro-2-methoxy-5-(propan-2-yl)phenyl-5-(trifluoromethyl)phenylmethyl) -4-methyl-1,3-oxazolidin-2-one

(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one

(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[2-(4-fluoro-5-isopropyl-2-methoxy-phenyl)-5-(trifluoromethyl)benzyl]-4-methyl-oxazolidin-2-one

(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-yl-phenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one

(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one

(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-2-oxazolidinone

(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-5-isopropyl-2-methoxy-phenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-oxazolidin-2-one

(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-5-isopropyl-2-methoxyphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-2-oxazolidinone

(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-2′-methoxy-5′-(1-methylethyl)-4-(trifluoromethyl)[1,1′-biphenyl]-2-yl]methyl]-4-methyl-2-oxazolidinone

(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-5′-isopropyl-2′-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one

(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4′-fluoro-2′-methoxy-5′-(propan-2-yl)-4-(trifluoromethyl)biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one

2226-70-2

95%

A0A090N8Q0_HUMAN

anacétrapib

anacetrapib(mk0859)

Anacetrapib-cis

anacetrapib;mk0859

anacetrapibum

CETP_HUMAN

Cholesteryl ester transfer protein

KCNH2_HUMAN

MFCD16294903

MK 0859;MK-0859;MK0859

NR1I2_HUMAN

анацетрапиб

أناسيترابيب

安塞曲匹